OnKure Therapeutics, Inc. (OKUR)
NASDAQ: OKUR · Real-Time Price · USD
5.90
0.00 (0.00%)
Jan 22, 2025, 10:36 AM EST - Market open
OnKure Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for OnKure Therapeutics stock have an average target of 36, with a low estimate of 33 and a high estimate of 40. The average target predicts an increase of 510.17% from the current stock price of 5.90.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 5, 2024.
Analyst Ratings
The average analyst rating for OKUR stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Initiates $33 | Buy | Initiates | $33 | +459.32% | Dec 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +577.97% | Nov 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +577.97% | Oct 17, 2024 |
| Oppenheimer | Oppenheimer | Buy Initiates $35 | Buy | Initiates | $35 | +493.22% | Oct 10, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
680.00K
EPS This Year
-2.70
from -2.93
EPS Next Year
-3.16
from -2.70
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | n/a | 2.1M | 2.1M |
| Avg | n/a | 680,003 | 1.0M |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | 208.8% |
| Avg | - | - | 50.0% |
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.13 | -1.28 | -0.50 |
| Avg | -2.70 | -3.16 | -0.49 |
| Low | -4.13 | -4.88 | -0.47 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.